期刊文献+

FHIT基因转染对肝癌细胞系HepG2的作用 被引量:3

Role of transfection of FHIT gene in human hepatocellular carci noma cell line HepG2
下载PDF
导出
摘要 目的:探讨外源性FH IT基因的表达对肝癌细胞株HepG2的影响.方法:用脂质体介导法将pcDNA3.1-FH IT及空载体pcDNA3.1(+)导入肝癌细胞系HepG2中,G418选择培养,经免疫组化和W estern b lotting鉴定其过表达.用流式细胞仪、普通光镜、透射电镜观察FH IT基因的表达对HepG2细胞凋亡和增殖的影响.结果:获得FH IT基因稳定表达的肝癌细胞株HepG2-FH IT.转染FH IT基因的HepG2细胞的生长速率明显下降,电镜下超微结构发生了凋亡早期改变,流式分析细胞的生长周期可见S/G2期阻滞.结论:外源性FH IT基因在体外通过诱导其凋亡及细胞周期俘获作用可有效抑制HepG2生长增殖. AIM: To study the role of transfection of FHIT gene into a human liver cancer cell line HepG2. METHODS: FHIT gene was transfected into human liver cancer cell line HepG2 by lipofectamine. After selection with G418, resistant colonies were obtained. The over-expression of FHIT was detected by immunochemistry and Western blotting methods. Apoptosis and cell cycle were analyzed by flow cytometry (FCM). The morphological changes were observed by light and electron microscope. RESULTS: Stable expression of FHIT protein in transfected HepG2 cells was obtained and the growth rate of these transfected HepG2 was inhibited. Early apoptosis was observed under transmission electron microscope and flow cytometry showed that the progression of cell cycle was arrested from S phase to G2 phase. CONCLUSION: The results indicate that FHIT gene can inhibit the growth and proliferation of HepG2 by inducing its apoptosis and cell cycle arrest in vitro.
出处 《第四军医大学学报》 北大核心 2005年第17期1579-1581,共3页 Journal of the Fourth Military Medical University
关键词 FHIT基因 基因转染 凋亡 肝癌 FHIT gene transfer apoptosis hepatocarcinoma
  • 相关文献

参考文献1

二级参考文献33

  • 1Croce CM, Sozzi G, Huebner K. Role of FHIT in human cancer. J Clin Oncol 1999; 17:1618-1624.
  • 2Huebner K, Druck T, Siprashvili Z, Croce CM, Kovatich A,McCue PA. The role of deletions at the FRA3B/FHIT locus in carcinogenesis. Recent Results Cancer Res 1998; 154:200-215.
  • 3Sorio C, Baron A, Orlandini S, Zamboni G, Pederzoli P, Huebner K, Scarpa A. The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers. Cancer Res 1999; 59:1308-1314.
  • 4Hadaczek P, Siprashvili Z, Markiewski M, Domagala W, Druck T, McCue PA, Pekarsky Y, Ohta M, Huebner K, Lubinski J. Absence or reduction of Fhit expression in most clear cell renal carcinomas. Cancer Res 1998; 58:2946-2951.
  • 5Werner NS, Siprashvili Z, Fong LY, Marquitan G, Schroder JK,Bardenheuer W, Seeber S, Huebner K, Schutte J, Opalka B. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression. Cancer Res 2000; 60:2780-2785.
  • 6Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT, Kim YT, Mok JE, Munoz N, Bosch FX, Shah K, Cho KR. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.Cancer Res 1997; 57:4692-4698.
  • 7Yoshino K, Enomoto T, Nakamura T, Nakashima R, Wada H,Saitoh J, Noda K, Murata Y. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix. Int J Cancer 1998; 76:176-181.
  • 8Druck T, Berk L, Huebner K. FHITness and cancer. Oncol Res 1998; 10:341-345.
  • 9Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar A.F, Minna JD. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res 1997; 57:2256-2267.
  • 10Sozzi G, Tornielli S, Tagliabue E, Sard L, Pezzella F, Pastorino U, Minoletti F, Pilotti S, Ratcliffe C, Veronese ML, Goldstraw P,Huebner K, Croce CM, Pierotti MA. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities.Cancer Res 1997; 57:5207-5212.

共引文献27

同被引文献22

  • 1袁林,沈世强,熊成龙,王军,章圆,王笛乐.抑癌基因FHIT在肝细胞癌中的研究[J].腹部外科,2004,17(4):250-251. 被引量:1
  • 2赵坡,宋欣,宁元元,李向红.肝细胞癌脆性组氨酸三联体Fhit蛋白表达丢失研究[J].中华肝胆外科杂志,2004,10(1):52-54. 被引量:11
  • 3孙昀,耿小平,朱立新,熊奇如,钱叶本,董桂银,李晓明.肝细胞癌中脆性组氨酸三联体基因的甲基化状况及其临床意义[J].中华外科杂志,2006,44(9):609-612. 被引量:13
  • 4Ohta M,Inoue H,Cotticelli MG,et al.The FHIT gene,spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t (3;8) breakpoint,is abnormal in digestive tract cancers[J].Cell,1996,84(4):587-597.
  • 5Baffa R,Veronese ML,Santoro R,et al.Loss of FHIT expression in gastric carcinoma[J].Cancer Res,1998,58(20):4 708-4 714.
  • 6Ishii H,Dumon KR,Vecchione A,et al.Effect of adenoviral transduction of the fragile histidine triad gene into esophsgeal cancer cells[J].Cancer Res,2001,61(4):1 578-1 584.
  • 7Gopalakrishnan VK,Banerjee AG,Vishwanatha JK,et al.Effect of FHIT gene replacement on growth,cell cycle and apoptosis in pancreatic cancer cells[J].Pancreatology,2003,3(4):293-302.
  • 8Roz L,Gremegna M,Ishii H,et al.Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines[J].Proc Natl Acad Sci USA,2002,99(6):3 615-3 620.
  • 9Sevignani C,Calin GA,Cesari R,et al.Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines[J].Cancer Res,2003,63(6):1 183-1 187.
  • 10Guo Z,Vishwanatha JK.Effect of regulated expression of the fragile histidine triad gene on cell cycle and proliferation[J].Mol Cell Biochem,2000,204(1-2):83-88.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部